We are live on ! Find out more
Ameriprise

Ameriprise Portfolio holdings

AUM $432B
1-Year Est. Return 30.22%
 

Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.

This Fund
S&P 500
This Quarter Est. Return
+6.73%
1 Year Est. Return
+30.22%
3 Year Est. Return
+89.37%
5 Year Est. Return
+112.58%
10 Year Est. Return
+443.56%
AUM
$286B
AUM Growth
+$60.1B
Cap. Flow
-$3.27B
Cap. Flow %
-1.14%
Top 10 Hldgs %
14.64%
Holding
3,869
New
237
Increased
1,955
Reduced
1,434
Closed
137

Sector Composition

Rank Sector Weight
1 Technology 15.6%
2 Financials 12.74%
3 Healthcare 11.15%
4 Industrials 7.88%
5 Consumer Discretionary 7.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HZO icon
2626
MarineMax
HZO
$759M
$2.72M ﹤0.01%
128,128
+4,370
+4% +$91.3K
MTOR
2627
DELISTED
MERITOR, Inc.
MTOR
$2.72M ﹤0.01%
140,526
+85,592
+156% +$1.8M
VRA icon
2628
Vera Bradley
VRA
$97M
$2.71M ﹤0.01%
177,860
+47,075
+36% +$687K
ODT
2629
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
$2.71M ﹤0.01%
139,449
-1,995
-1% -$40.7K
NTLA icon
2630
Intellia Therapeutics
NTLA
$1.49B
$2.7M ﹤0.01%
94,381
-9,640
-9% -$280K
DAKT icon
2631
Daktronics
DAKT
$955M
$2.7M ﹤0.01%
343,908
+60,212
+21% +$495K
ESND
2632
DELISTED
Essendant Inc.
ESND
$2.69M ﹤0.01%
210,240
+2,585
+1% +$37K
IVOG icon
2633
Vanguard S&P Mid-Cap 400 Growth ETF
IVOG
$1.62B
$2.69M ﹤0.01%
37,234
-218
-0.6% -$15.7K
AVD icon
2634
American Vanguard Corp
AVD
$68.4M
$2.69M ﹤0.01%
149,656
+5,745
+4% +$119K
AMC icon
2635
AMC Entertainment Holdings
AMC
$2.52B
$2.69M ﹤0.01%
13,095
-13,714
-51% -$2.48M
JPGE
2636
DELISTED
JPMorgan Diversified Return Global Equity ETF
JPGE
$2.68M ﹤0.01%
43,738
-203,881
-82% -$12.4M
CLVS
2637
DELISTED
Clovis Oncology, Inc.
CLVS
$2.68M ﹤0.01%
91,273
-403,171
-82% -$15.6M
ACIC icon
2638
American Coastal Insurance
ACIC
$515M
$2.68M ﹤0.01%
119,647
+7,665
+7% +$158K
FORR icon
2639
Forrester Research
FORR
$223M
$2.67M ﹤0.01%
58,123
+2,585
+5% +$119K
LCUT icon
2640
Lifetime Brands
LCUT
$191M
$2.67M ﹤0.01%
244,766
+4,800
+2% +$57.3K
CRD.A icon
2641
Crawford & Co Class A
CRD.A
$532M
$2.65M ﹤0.01%
294,948
+191,065
+184% +$1.64M
SECO
2642
DELISTED
Secoo Holding Limited ADR
SECO
$2.65M ﹤0.01%
20,861
-44,120
-68% -$5.58M
CS
2643
DELISTED
Credit Suisse Group
CS
$2.64M ﹤0.01%
177,634
+26,375
+17% +$402K
SHYF
2644
DELISTED
The Shyft Group
SHYF
$2.63M ﹤0.01%
178,597
+3,691
+2% +$55.2K
LL
2645
DELISTED
LL Flooring Holdings, Inc.
LL
$2.62M ﹤0.01%
169,101
-8,150
-5% -$164K
SUP
2646
DELISTED
Superior Industries International
SUP
$2.62M ﹤0.01%
153,541
+25,555
+20% +$491K
ACMR icon
2647
ACM Research
ACMR
$5.42B
$2.62M ﹤0.01%
708,753
-245,664
-26% -$1.04M
LYG icon
2648
Lloyds Banking Group
LYG
$89.5B
$2.62M ﹤0.01%
860,483
-8,039
-0.9% -$25.8K
AAOI icon
2649
Applied Optoelectronics
AAOI
$7.57B
$2.61M ﹤0.01%
105,731
-3,089
-3% -$121K
CISN
2650
DELISTED
Cision Ltd. Ordinary Share
CISN
$2.6M ﹤0.01%
155,080
+67,400
+77% +$1.11M

Similar funds

Ameriprise's Q3 2018 Portfolio in Review

As of Q3 2018, Ameriprise held 3,869 positions worth $286B, up 27% from $226B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Ameriprise's Q3 2018 filing shows 237 new, 1,955 increased, 1,434 reduced and 137 closed positions. Its largest new stake was Fortive Corporation 5.00% Mandatory Convertible Preferred Stock, Series A: 55,160 shares worth $58.8M. The largest sale was Applied Materials, an estimated $397M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Financials and Healthcare.

  • Ameriprise's largest Q3 2018 buy was Fortive Corporation 5.00% Mandatory Convertible Preferred Stock, Series A: 55,160 shares worth $58.8M.
  • Ameriprise added most to Lockheed Martin in Q3 2018, an estimated $327M increase.
  • Ameriprise's biggest Q3 2018 reduction was Applied Materials, cutting an estimated $397M.
  • Ameriprise fully exited Cavium, Inc. in Q3 2018, selling an estimated $172M.
  • Ameriprise's ten largest holdings make up 15% of its $286B portfolio in Q3 2018.
  • Ameriprise opened 237 new positions and closed 137 in Q3 2018.
  • Ameriprise's portfolio value rose 27% quarter-over-quarter to $286B.

Based on Ameriprise's 13F filing for Q3 2018, filed 14 Nov 2018.